Skip to content

Medical-device intelligence

Medical Analysis Systems, Inc.: FDA clearances and recalls

Research Medical Analysis Systems, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

107 clearance records and 0 recall records in the covered releases, across 1 source company names and 38 product codes. Dated history runs from Feb 7, 1978 to Nov 5, 2004.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

107 matching records
Device / recordCompany in FDA recordSourceSource date
MAS, DADE AND LIQUID ASSAYED DIABETES CONTROLK042717 · JJXMedical Analysis Systems, Inc.510(k)Nov 5, 2004FDA decision date
ABBOTT ARCHITECT STAT TROPONIN I LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL L, M AND HK041194 · JJXMedical Analysis Systems, Inc.510(k)Aug 16, 2004FDA decision date
MAS CARDIOIMMUNE TL LIQUID ASSAYED CARDIAC MARKER CONTROL, LEVELS 1,2 AND 3K040880 · JJYMedical Analysis Systems, Inc.510(k)Apr 28, 2004FDA decision date
MAS PAR TDMK032826 · DIFMedical Analysis Systems, Inc.510(k)Oct 9, 2003FDA decision date
MAS CARDIOIMMUNE PROBNP, MAS CARDIOIMMUNE TLK032335 · JJYMedical Analysis Systems, Inc.510(k)Aug 19, 2003FDA decision date
MAS BILIRUBIN LIQUID ASSAYED BILIRUBIN CONTROLK031890 · JJXMedical Analysis Systems, Inc.510(k)Jul 16, 2003FDA decision date
MAS TOX AMMONIA CONTROLLIQUID ASSAYED TOX AMMONIA CONTROLK031392 · DKCMedical Analysis Systems, Inc.510(k)Jul 1, 2003FDA decision date
URICHEMTRAK LIQUID ASSAYED URINE CONTROLK031441 · JJWMedical Analysis Systems, Inc.510(k)Jul 1, 2003FDA decision date
MAS CARDIOLMMUNE PROBNP LIQUID ASSAYED CARDIAC MARKER CONTROL LEVEL 1, 2 AND 3K031364 · JJYMedical Analysis Systems, Inc.510(k)May 30, 2003FDA decision date
MAS CHEMTRAK H & DADE MONI-TROL H LIQUID ASSAYED CHEMISTRY CONTROLK030942 · JJYMedical Analysis Systems, Inc.510(k)Apr 28, 2003FDA decision date
MAS LIPID LEVEL 1 AND 2K030679 · JJYMedical Analysis Systems, Inc.510(k)Mar 14, 2003FDA decision date
MAS CARDIOIMMUNE TL LOW LEVEL LIQUID ASSAYED CARDIAC MARKER CONTROL, DADE CARDIAC TL LOW LEVEL LIQUID ASSAYED CARDIAC MAK023669 · JJYMedical Analysis Systems, Inc.510(k)Dec 19, 2002FDA decision date
MAS T-MARKER, LEVEL 1,2 AND 3, DADE SPECIAL-T MARKER, LEVEL 1,2 AND 3K023867 · JJYMedical Analysis Systems, Inc.510(k)Dec 17, 2002FDA decision date
MAS UA CONTROL LIQUID ASSAYED URINALYSIS CONTROL, DADE ASSAYED URINALYSIS CONTROLK023928 · JJWMedical Analysis Systems, Inc.510(k)Dec 11, 2002FDA decision date
MAS DIABETES CONTROL - LYOPHILIZED ASSAYED DIABETES CONTROLK023307 · JJXMedical Analysis Systems, Inc.510(k)Oct 31, 2002FDA decision date
MAS UA CONTROL, DADE UA CONTROL- LIQUID ASSAYED URINALYSIS CONTROLK021155 · JJWMedical Analysis Systems, Inc.510(k)Apr 29, 2002FDA decision date
MODIFICATION TO MAS CARDIOLMMUNE TL; DADE CARDIAC TLK013995 · JJYMedical Analysis Systems, Inc.510(k)Dec 21, 2001FDA decision date
MAS LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVEL 1 AND 2, DADE LIPID CONTROL, LIQUID ASSAYED LIPID CONTROL, LEVELK013734 · JJYMedical Analysis Systems, Inc.510(k)Dec 7, 2001FDA decision date
TRI-POINT LIQUIMMUNE LIQUID ASSAYED CONTROL LEVELS 1,2, AND 3K011731 · JJYMedical Analysis Systems, Inc.510(k)Jul 5, 2001FDA decision date
CHEMTRAK PLATINUM COMPREHENSIVE LIQUID ASSAYED CHEMISTRY AND TDM CONTROL LEVELS 1, 2, 3K011548 · JJYMedical Analysis Systems, Inc.510(k)Jun 18, 2001FDA decision date
CARDIOIMMUNE TL CARDIAC MARKER CONTROL LEVELS 1, 2, 3, AND MULTI-PACKK010111 · JJYMedical Analysis Systems, Inc.510(k)Feb 28, 2001FDA decision date
DADE TRU-LIQUID MONI-TROL CHEMISTRY CONTROL LEVELS 1, MID, 2, AND S (ASSAYED)K001758 · JJYMedical Analysis Systems, Inc.510(k)Jul 5, 2000FDA decision date
TRI-POINT, LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL, LEVELS 1, 2, AND 3K993546 · JJYMedical Analysis Systems, Inc.510(k)Nov 30, 1999FDA decision date
CASCADE LIQUID COAGULATION CONTROL LEVELS 1, 2, AND 3K992829 · GGNMedical Analysis Systems, Inc.510(k)Nov 22, 1999FDA decision date
CARDIOIMMUNE CARDIAC MARKER CONTROL LEVELS 1,2, AND 3K992430 · JJTMedical Analysis Systems, Inc.510(k)Aug 30, 1999FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗